156 related articles for article (PubMed ID: 34087869)
41. All-trans-retinoic acid in acute promyelocytic leukemia.
Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
[TBL] [Abstract][Full Text] [Related]
42. Oral arsenic trioxide, all-trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long-term results and unique prognostic indicators.
Gill HS; Yim R; Kumana CR; Tse E; Kwong YL
Cancer; 2020 Jul; 126(14):3244-3254. PubMed ID: 32365228
[TBL] [Abstract][Full Text] [Related]
43. [Remission of acute promyelocytic leukemia after all-trans-retinoic acid].
Knobel B; Sommer I; Meytes D
Harefuah; 1992 Dec; 123(11):445-8, 507. PubMed ID: 1487198
[TBL] [Abstract][Full Text] [Related]
44. Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
Dang CC; Guan YK; Lau NS; Chan SY
J Oncol Pharm Pract; 2020 Dec; 26(8):2034-2037. PubMed ID: 32279594
[TBL] [Abstract][Full Text] [Related]
45. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Escudier SM; Kantarjian HM; Estey EH
Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
[TBL] [Abstract][Full Text] [Related]
46. Does acute promyelocytic leukemia patient with the STAT5B/RARa fusion gene respond well to decitabine?: A case report and literature review.
Wang L; Yan X; He J
Medicine (Baltimore); 2020 Oct; 99(43):e22923. PubMed ID: 33120845
[TBL] [Abstract][Full Text] [Related]
47. The simpler, the better: oral arsenic for acute promyelocytic leukemia.
Zhu HH; Hu J; Lo-Coco F; Jin J
Blood; 2019 Aug; 134(7):597-605. PubMed ID: 31113776
[TBL] [Abstract][Full Text] [Related]
48. Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
Thomas X; Dombret H; Cordonnier C; Pigneux A; Gardin C; Guerci A; Vekhoff A; Sadoun A; Stamatoullas A; Fegueux N; Maloisel F; Cahn JY; Reman O; Gratecos N; Berthou C; Huguet F; Kotoucek P; Travade P; Buzyn A; de Revel T; Vilque JP; Naccache P; Chomienne C; Degos L; Fenaux P
Leukemia; 2000 Jun; 14(6):1006-13. PubMed ID: 10865965
[TBL] [Abstract][Full Text] [Related]
49. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.
Avvisati G; Lo Coco F; Diverio D; Falda M; Ferrara F; Lazzarino M; Russo D; Petti MC; Mandelli F
Blood; 1996 Aug; 88(4):1390-8. PubMed ID: 8695858
[TBL] [Abstract][Full Text] [Related]
50. Reduced medical costs and hospital days when using oral arsenic plus ATRA as the first-line treatment of acute promyelocytic leukemia.
Jiang H; Liang GW; Huang XJ; Jiang Q; Han S; Shi LW; Zhu HH
Leuk Res; 2015 Dec; 39(12):1319-24. PubMed ID: 26403986
[TBL] [Abstract][Full Text] [Related]
51. CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.
Burry LD; Seki JT
Ann Pharmacother; 2002 Dec; 36(12):1900-6. PubMed ID: 12452754
[TBL] [Abstract][Full Text] [Related]
52. [Effects of combination therapy with all-trans retinoic acid and arsenic trioxide on acute promyelocytic leukemia].
Zhang GC; Zheng D; Li QH; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
Ai Zheng; 2004 Apr; 23(4):430-4. PubMed ID: 15087033
[TBL] [Abstract][Full Text] [Related]
53. Clinical features and treatment outcomes of pediatric acute promyelocytic leukemia in a Mexican pediatric hospital.
Dorantes-Acosta E; Medina-Sanson A; Jaimes-García Y; López-Martínez B
Rev Invest Clin; 2013; 65(5):392-8. PubMed ID: 24687338
[TBL] [Abstract][Full Text] [Related]
54. Successful treatment of retinoic acid syndrome with dexamethasone: a case report.
Leelasiri A; Numbenjapol T; Prayoonwiwat W; Mongkolsritrakul W; Srisawat C
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S302-10. PubMed ID: 16858973
[TBL] [Abstract][Full Text] [Related]
55. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
[TBL] [Abstract][Full Text] [Related]
56. 4-oxo retinoic acid for refractory acute promyelocytic leukemia in children with all-trans retinoic acid therapy.
Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
J Nutr Sci Vitaminol (Tokyo); 1995 Aug; 41(4):493-8. PubMed ID: 8676222
[TBL] [Abstract][Full Text] [Related]
57. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
[TBL] [Abstract][Full Text] [Related]
58. [Complete remission of acute promyelocytic leukemia resisting all-trans retinoic acid of one case treated by tanshinone II A].
Yang YM; Liu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):965-7. PubMed ID: 17236602
[TBL] [Abstract][Full Text] [Related]
59. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Cervera J; Montesinos P; Hernández-Rivas JM; Calasanz MJ; Aventín A; Ferro MT; Luño E; Sánchez J; Vellenga E; Rayón C; Milone G; de la Serna J; Rivas C; González JD; Tormo M; Amutio E; González M; Brunet S; Lowenberg B; Sanz MA
Haematologica; 2010 Mar; 95(3):424-31. PubMed ID: 19903674
[TBL] [Abstract][Full Text] [Related]
60. All-trans retinoic acid as an alternative to chemotherapy in the treatment of acute promyelocytic leukemia.
Kühne T; Imbach P; Signer E; Osterwalder B
Pediatr Hematol Oncol; 1993; 10(4):363-7. PubMed ID: 8292523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]